Stage A Heart Failure Modern Strategies for an Effective Prevention

被引：5

作者：

Faggiano, Pompilio ^{[1
,2
]}

Bernardi, Nicola ^{[3
]}

Calvi, Emiliano ^{[3
]}

Bonelli, Andrea ^{[3
]}

Faggiano, Andrea ^{[4
]}

Bursi, Francesca ^{[5
]}

Bosisio, Marco ^{[3
]}

机构：

[1] Univ Brescia, Cardiol, Via 4 Novembre 7, I-25122 Brescia, Italy

[2] Fdn Poliambulanza, Via 4 Novembre 7, I-25122 Brescia, Italy

[3] Univ Brescia, Spedali Civili, Div Cardiol, Piazzale Spedali Civili 1, I-25123 Brescia, Italy

[4] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Via Francesco Sforza 28, I-20122 Milan, Italy

[5] Univ Milan, ASST Santi Paolo & Carlo, Heart & Lung Dept, Div Cardiol,San Paolo Hosp, Via Antonio di Rudini 8, I-20142 Milan, Italy

来源：

HEART FAILURE CLINICS | 2021年 / 17卷 / 02期

关键词：

Heart failure; Cardiovascular risk factors; Preventive cardiology; Stage A heart failure; Early intervention; BODY-MASS INDEX; BLOOD-PRESSURE; ATHEROSCLEROSIS RISK; NATRIURETIC PEPTIDE; OUTCOMES; ASSOCIATION; MORTALITY; OBESITY;

D O I：

10.1016/j.hfc.2021.01.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Stage A heart failure (HF) patients do not show HF symptoms or any structural heart disease but are at risk of HF development. Cardiovascular risk factors (hypertension, diabetes, metabolic syndrome, sedentary lifestyle, poor diet, and exposure to cardiotoxic agents) characterize subjects affected by stage A HF. It is essential to identify these subjects early and ensure that, despite being asymptomatic, they grasp the importance of undertaking correct lifestyle and therapeutic interventions. A careful stratification of asymptomatic subject's risk profile is needed to adopt proper preventive strategies and to set individualized therapeutic targets that avoid progression to advanced stages of HF. © 2021 Elsevier Inc.

引用

页码：167 / 177

页数：11

共 50 条

[31] Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach
Issa, Victor Sarli
Andrade, Lucia
Bocchi, Edimar Alcides
CLINICS, 2013, 68 (03) : 401 - 409
[32] From hypertension to heart failure -: Are there better primary prevention strategies?
Meredith, Peter A.
Oestergren, Jan
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2006, 7 (02) : 64 - 73
[33] Heart Failure Prevention Is the Best Option To Stem High Costs and Disease Burden Research for More Effective Heart Failure Treatment Is Needed
Desvigne-Nickens, Patrice
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (02): : 143 - 145
[34] The Prevention of the New Onset of Heart Failure in Hypertensive Patients
Kiuchi, Shunsuke
Ikeda, Takanori
INTERNAL MEDICINE, 2024, 63 (01) : 11 - 15
[35] Understanding Heart Failure in Women With Preeclampsia A Call for Prevention
Honigberg, Michael C.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (23) : 2291 - 2293
[36] Is Foxglove Effective in Heart Failure?
Chaggar, Parminder S.
Shaw, Steven M.
Williams, Simon G.
CARDIOVASCULAR THERAPEUTICS, 2015, 33 (04) : 236 - 241
[37] Advances in detection, prevention and treatment of heart failure in type 2 diabetes: part II
Cowley, Alice C.
Dattani, Abhishek
Brady, Emer M.
Mccann, Gerry P.
Gulsin, Gaurav S.
BRITISH JOURNAL OF DIABETES, 2024, 24 (01): : 24 - 29
[38] Intensive Blood Pressure Lowering for Prevention of Heart Failure With Preserved and Reduced Ejection Fractions
Rethy, Leah
Cohen, Jordana B.
CIRCULATION-HEART FAILURE, 2021, 14 (12)
[39] Heart Failure Primary Prevention: What Does SPRINT Add? Recent Advances in Hypertension
Raby, Kirsten
Rocco, Michael
Oparil, Suzanne
Gilbert, Olivia N.
Upadhya, Bharathi
HYPERTENSION, 2021, 77 (06) : 1804 - 1814
[40] Anatomy of the obesity paradox in heart failure
Guglin, Maya
Baxi, Khyati
Schabath, Mathew
HEART FAILURE REVIEWS, 2014, 19 (05) : 621 - 635

← 1 2 3 4 5 →